IL33 and atherosclerosis: It is well known that the interleukin 33 (IL‐33)/interleukin 1 receptor‐like 1 (ST2) pathway plays an important role in pathogenesis of cardiovascular disease such as atherosclerosis, heart failure and hypertension 6, 7.